Carsten Bokemeyer

Research interests

Publications

• Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

  Nature · 2023 · https://doi.org/10.1038/s41586-023-05728-y

• Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03296

• Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03292

• Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

  Annals of Internal Medicine · 2020 · https://doi.org/10.7326/m20-2003

• ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy217

• Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx758

• Guidelines on Testicular Cancer: 2015 Update

  European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.07.044

• Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials

  European Journal of Cancer · 2012 · https://doi.org/10.1016/j.ejca.2012.02.057

• Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

  Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds579

• Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

  Annals of Oncology · 2011 · https://doi.org/10.1093/annonc/mdq632

• Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

  New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa1000067

• The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

  International Journal of Cancer · 2010 · https://doi.org/10.1002/ijc.25423

• Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.21.6663

• European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

  European Urology · 2008 · https://doi.org/10.1016/j.eururo.2007.12.024

• Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.20.8397

• Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

  New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0802656

• Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

  The Lancet Oncology · 2008 · https://doi.org/10.1016/s1470-2045(08)70002-0

• Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.13.9378

• Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment

  Oncology · 2005 · https://doi.org/10.1159/000083128

• European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

  Annals of Oncology · 2004 · https://doi.org/10.1093/annonc/mdh301

• The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

  European Journal of Cancer · 2004 · https://doi.org/10.1016/j.ejca.2004.06.019

• POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

  PubMed · 2003

• Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group

  Journal of Clinical Oncology · 2001 · https://doi.org/10.1200/jco.2001.19.10.2647

• High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.

  Journal of Clinical Oncology · 1994 · https://doi.org/10.1200/jco.1994.12.6.1223

Current projects

No projects listed.